NORTHWESTERN MEDICINE EXPERTS AT Ats 2025

The American Thoracic Society (ATS) will hold its International Conference this year from May 18 through 21 in San Francisco, California with pre-conference programs from May 16 through 17.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. This year, several Northwestern Medicine pulmonologists and thoracic surgeons will be attending to share ideas and present their research at ATS 2025. View our presentation schedule and pre-conference interviews with several physicians attending this year's conference below.

NORTHWESTERN MEDICINE PRESENTATION HIGHLIGHTS

Date
​Time
Location
Session
Presenter
Sunday, May 18th
9:15 - 10:45 am PT
​(9:38 - 9:56 am PT)
SYMP2​
Host-Directed Therapies in Pneumonia​

A9 Advancing Host-Directed Therapies in Pulmonary Infections: Bridging Research and Clinical Practice
Chiagozie Pickens, MD, MSci ​
12:00 - 1:00 pm PT
​(12:05 - 12:15 pm PT)
The American Lung Association Lung Health Cohort (ALA-LHC): The First 2,000 Participants

MD2 Study Updates from the American Lung Association's Airway Clinical Research Centers Network
Ravi Kalhan, MD, MS​
12:00 - 1:00 pm PT
​(12:10 - 12:30 pm PT)
The Neu-Lung Consortium: Neutrophilic Mechanisms of Inflammation, Injury, and Repair in Lung and Airways Diseases
​
MD10 Neutrophilic Mechanisms of Inflammation, Injury, and Repair in Lung Diseases
Benjamin D. Singer, MD, ATSF
3:16 - 3:30 pm PT
​(3:16 - 3:30 pm PT)
CT2
Navigating the New Insurance Minefield- the Arrival of AI

A48 Navigating the New Landscape in Home Ventilation
Lisa Freeman. Wolfe, MD​
2:15 - 3:45 pm PT
(3:00 - 3:23 pm PT)
SYMP5
Machine Learning in Identifying Mortality Risks in Respiratory Diseases

A89 Revolutionizing Respiratory Disease Management with Machine Learning and AI Insights
Benjamin D. Singer, MD, ATSF
2:15 - 4:15 pm PT
​(2:27 - 2:39 pm PT)
Room 2001 (West Building, Level 2), Moscone Center  
MUC5B Promoter Polymorphism and a Proteomics Biomarker Score of Radiologically-defined Interstitial Resilience
​
A95 New and Exciting Biomarkers in LLD
Anthony Joseph. Esposito, MD and Ravi Kalhan, MD, MS
2:15 - 4:15 pm PT
(3:15 - 3:27 pm PT)
Room 3005/3007 (West Building, Level 3), Moscone Center 
Identifying Windows of Opportunity for Early Mobilization of Mechanically Ventilated Patients: Multi-center Comparative Analysis of Clinical Trial and Consensus Guideline Eligibility Criteria

​A97 From Surviving to Thriving: Understanding and Improving Long Term Outcomes After Critical Illness
Catherine Gao, MD​
Monday, May 19th
9:15 – 10:45 am PT (10:30 - 10:45 am PT)
CT1
Con: All Spontaneous Pneumothoraces Should Be Managed Conservatively in the Absence of Significant Symptoms and Hemodynamic Compromise

B3 Non-Malignant Pleural Disease - A Pro/Con Debate
​Momen M. Wahidi, MD, MBA
Tuesday, May 20th
​9:15 – 10:45 am PT
Pneumonia and Pulmonary Infections

C1 Clinical Year in Review
Chiagozie Pickens, MD, MSci
​9:15 – 11:15 am PT (10:27 - 10:39 am PT)
Room 2009/2011 (West Building, Level 2), Moscone Center
Patient Preferred Language and Deep Sedation During Invasive Mechanical Ventilation: A Multicenter Retrospective Cohort Study

C17 Delirium, Disparities, and Disability: Advancing Equity in Critical Illness Outcomes
​Catherine Gao, MD
​9:15 – 10:45 am PT
​(9:56 - 10:14 am)
SYMP4
​AT2 Epithelial Stem Cells and Integrated Stress Response

C9 Many Faces of Alveolar Type II Cells- Plasticity in Health and Disease
Seunghye Han, MD, MPH​
2:15 – 4:15 pm PT
​(3:27 - 3:39 pm PT)
Room 2001 (West Building, Level 2), Moscone Center
CT-based Discrimination of CTEPH Using Deep Learning Clot Vessel Radiomics and Machine Learning

C98 Palace Of Fine Arts: Innovative Therapeutic Approaches And Survival Prediction In Pulmonary Hypertension
Michael J. Cuttica, MS, MD and Ruben Mylvaganam, MD​
​Wednesday, May 21st
8:15 - 9:15 am PT (8:25 - 8:35 am PT)
COMM SYMP
ICU Managment of PGD in the Lung Transplant Patient

D10 Insights Into Acute Lung Injury Revealed Through Lung Transplantation 
​Nandita R. Nadig, MD, MSci, ATSF
​11:00 am – 1:00 pm PT (11:36 - 11:48 am PT)
Room 2018 (West Building, Level 2), Moscone Center
The Association of Sex and Height With Low-tidal Volume Ventilation in a Multi-center Cohort of Critically Ill Adults

D93 Supporting Life Around The Globe: Oxygen, Ventilation, And Cardiac Arrest Science
Catherine Gao, MD​
11:00 am – 1:00 pm PT (11:12 - 11:24 am PT)
Room 3001 (West Building, Level 3), Moscone Center
Profibrotic Monocyte-Derived Alveolar Macrophages Are Associated With Disease Severity in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease 

D97 Immune-epithelial Interactions And Lung Repair In Injury And Repair
​Anthony Joseph. Esposito, MD and
​G. Scott Budinger, M.D., A.T.S.F.
11:00 am – 1:00 pm PT (11:24 - 11:36 am PT)
​Room 3001 (West Building, Level 3), Moscone Center
​Profibrotic Monocyte-Derived Alveolar Macrophages Are Associated With Disease Severity in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease 

D97 Immune-epithelial Interactions And Lung Repair In Injury And Repair
Benjamin D. Singer, MD, ATSF​

Follow Northwestern Medicine PULMONOLOGY